Abstract:Objectives: This study was conducted to investigate the potential equivalence in clinical efficacy and assess safety of a 5 or 7 day regimen of oral telithromycin (800 mg once daily) and a 10 day regimen of oral clarithromycin (500 mg twice daily) in treating community-acquired pneumonia (CAP). Bacteriological efficacy was also compared. Methods: This was a multicentre, randomized, double-blind, active-controlled study. Patients with mild to moderate CAP received telithromycin 800 mg once a day for 5 (n=193) or 7 (n=195) days or clarithromycin 500 mg twice a day for 10 days (n=187). In these groups, 159, 161 and 146 patients, respectively, completed the study. Results: At the post-therapy/test-of-cure evaluation, clinical cure rates (per-protocol clinical population) were 89.3% (5 days) and 88.8% (7 days) for telithromycin, and 91.8% for clarithromycin 10 days. Satisfactory bacteriological outcome rates (per-protocol bacteriological population) were 87.7% and 80.0% for 5 and 7 days of telithromycin, respectively, and 83.3% for 10 days of clarithromycin. Bacteriological eradication rates in the respective treatment groups were, for Streptococcus pneumoniae, 95.8% (23/24), 96.7% (29/30) and 88.5% (23/26); for Haemophilus influenzae, 88.0% (22/25), 84.0% (21/25) and 88.2% (15/17) and for Moraxella catarrhalis, 1/1, 4/5 and 3/4. Both telithromycin regimens demonstrated clinical efficacy against pneumococcal bacteraemia (19/19), atypical pathogens (9/9) and erythromycin-resistant S. pneumoniae isolates (5/5). Most treatment-emergent adverse events were mild to moderate in intensity with most commonly reported adverse events involving the gastrointestinal system. Conclusions: Telithromycin 800 mg administered once a day for 5 or 7 days was as effective and safe as clarithromycin 500 mg administered twice a day for 10 days in treating patients with CAP caused by common respiratory pathogens, including macrolide-resistant isolates, and pneumococcal bacteraemia.

A randomized, double-blinded, double-modelling and controlled clinical and bacteriological evaluation of erythromycin cyclic 11,12-carbonate in the treatment of bacterial infection compared with roxithromycin

A Randomized Controlled Clinical Trial on Injective Azithromycin Versus Erythromycin in the Treatment of Respiratory Tract Bacterial Infections.

Efficacy and Safety of Roxithromycin/ambroxol Dispersible Tablets in Patients with Acute Bacterial Lower Respiratory Tract Infection

Isotretinoin Erythromycin Gel in the Treatment of Acne Vulgaris: a Multicenter Randomized Parallel-Controlled Clinical Study

Multicenter Randomized Controlled Clinical Trial on Teicoplanin Versus Vancomycin

A Randomized Double-blind Control Clinical Study on Moxifloxacin for Treatment of Bacterial Skin Infections

Efficacy and safety of roxithromycin/ambroxol in patients with lower respiratory tract infection

A Randomized Multicenter Clinical Study of Cefpodoxime Proxetil Tablets in Treatment of Acute Bacterial Infections in 158 Patients

Clinical Comparative Study of Injectable Azithromycin and Cefuroxime in the Treatment of Lower Respiratory Tract Infection

Clinical Study of Cefprozil in Treatment of Respiratory Tract Infections

Efficacy and safety of Azithromycin and Erythromycin for respiratory mycoplasma infection in children: a meta-analysis

A clinical trial on ceftriaxone 1g daily in treatme nt of lower respiratory tract infection

Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia

Clinical evaluation of azithromycin sequential therapy in the treatment of 138 patients with community-acquired pneumonia

A Multi-Center, Randomized, Controlled, Double Blind and Double Dummy Clinical Trial of Antofloxacin Hydrochloride Tablet Versus Levofloxacin Tablet for the Treatment of Acute Bacterial Infections

A randomized comparative study of gatifloxacin and ciprofloxacin in the treatment of bacterial infections

The Efficacy and Safety of Azithromycin in Asthma: A Systematic Review

Analysis of the Efficacy of Erythromycin Cyclic 11,12-Carbonate Combined with Azithromycin in the Treatment of Severe Mycoplasma Pneumoniae Pneumonia in Children and its Effect on Cytokines

Clinical Efficacy of Azithromycin in Treatment of Children’s Mycoplasma Pneumonia

Effect of Roxithromycin Controlling Chlamydia Pneumoniae Infection on the Incidence of Adverse Cardiovascular Events

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers